Compare ASRV & CPIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ASRV | CPIX |
|---|---|---|
| Founded | 1983 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.4M | 92.3M |
| IPO Year | 1994 | 2007 |
| Metric | ASRV | CPIX |
|---|---|---|
| Price | $5.11 | $7.86 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 29.4K | ★ 119.4K |
| Earning Date | 04-21-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.16% | N/A |
| EPS Growth | ★ 61.90 | 58.70 |
| EPS | ★ 0.27 | N/A |
| Revenue | $14,634,000.00 | ★ $42,010,949.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $45.55 | ★ N/A |
| Revenue Growth | N/A | ★ 16.75 |
| 52 Week Low | $2.80 | $1.85 |
| 52 Week High | $5.19 | $8.45 |
| Indicator | ASRV | CPIX |
|---|---|---|
| Relative Strength Index (RSI) | 69.48 | 57.82 |
| Support Level | $3.62 | $5.55 |
| Resistance Level | $5.19 | $7.97 |
| Average True Range (ATR) | 0.23 | 0.73 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 88.42 | 77.12 |
AmeriServ Financial Inc is a bank holding company. The company and its subsidiaries derive substantially all of their income from banking, bank-related services, and trust-related services. Its operating segment includes community banking and it generates maximum revenue. The community banking segment includes both retail and commercial banking activities. The company also offers retail banking which includes the deposit-gathering branch franchise and lending to both individuals and small businesses; Lending activities include residential mortgage loans, direct consumer loans, and small business commercial loans; Commercial banking to businesses includes commercial loans, business services, and CRE loans.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.